Overview
People may vary widely across many dimensions despite having the same diagnosis, which can make effective treatment a challenge. Stratified medicine aims to identify groups of people within a diverse disease population who share unique characteristics (such as underlying mechanisms, risk factors, disease trajectories, or treatment responses) to inform treatment approaches that are tailored for these groups (or strata). This webinar focuses on the value of stratification as a tool for driving transformative change in early interventions for people with anxiety, depression, and psychosis.
Speaker
Lynsey Bilsland, Ph.D.
Head of Mental Health Translation
Wellcome Trust
Lynsey Bilsland, Ph.D., is Head of the Mental Health Translation team at Wellcome Trust, which aims to develop a portfolio of funded projects that enable identification, prediction, and early intervention in mental health problems. Dr. Bilsland also developed and led the Innovations Psychosis Flagship, which aimed to reduce the global burden of psychosis by developing innovations to improve patient outcomes ultimately.
Speaker
Usman Hamdani, Ph.D.
Research Lead, Mental Health Translation
Wellcome Trust
Usman Hamdani, Ph.D., is the Research Lead in the Mental Health Translation team at Wellcome Trust, where he leads the portfolio of non-pharmacological interventions and stratification in mental health research. Before joining Wellcome, Dr. Hamdani was extensively involved in conducting cutting-edge trials of psychosocial interventions in global mental health research and policy impact in low-resource settings.